El-Nile Co For Pharmaceuticals And Chemical Industries - ElNile (CAI:NIPH) Total Operating Expense: E£363 Mil (TTM As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

CAI:NIPH El-Nile Co For Pharmaceuticals And Chemical Industries - ElNile CAI:NIPH
28 GF Score
Price E£184.90
! 9 Warning Signs
View Full Analysis

What is El-Nile Co For Pharmaceuticals And Chemical Industries - ElNile Total Operating Expense?

El-Nile Co For Pharmaceuticals And Chemical Industries - ElNile CAI:NIPH +4.93% 28 Total Operating Expense is E£363 Mil as of Mar. 2026. GuruFocus rates CAI:NIPH with a GF Score™ of 28/100. The stock has 9 warning signs investors should review.

El-Nile Co For Pharmaceuticals And Chemical Industries - ElNile's Total Operating Expense for the three months ended in Mar. 2026 was E£192 Mil. El-Nile Co For Pharmaceuticals And Chemical Industries - ElNile's Total Operating Expense for the trailing twelve months (TTM) ended in Mar. 2026 was E£363 Mil.

El-Nile Co For Pharmaceuticals And Chemical Industries - ElNile Total Operating Expense Related Terms

El-Nile Co For Pharmaceuticals And Chemical Industries - ElNile Total Operating Expense Historical Data

* Premium members only.

The historical data trend for El-Nile Co For Pharmaceuticals And Chemical Industries - ElNile's Total Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

El-Nile Co For Pharmaceuticals And Chemical Industries - ElNile Total Operating Expense Chart

El-Nile Co For Pharmaceuticals And Chemical Industries - ElNile Annual Data
Trend Jun24 Jun25
Total Operating Expense
108.92 119.07

El-Nile Co For Pharmaceuticals And Chemical Industries - ElNile Quarterly Data
Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Operating Expense Get a 7-Day Free Trial 116.32 107.41 29.55 34.69 191.59
CAI:NIPH
28GF Score
El-Nile Co For Pharmaceuticals And Chemical Industries - ElNile CAI:NIPH
Total Operating Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

El-Nile Co For Pharmaceuticals And Chemical Industries - ElNile Total Operating Expense Calculation

Total Operating Expense is the primary recurring expense associated with central operations that are incurred in order to generate sales.


Total Operating Expense for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was E£363 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Total Operating Expense of E£363 Mil mean?
El-Nile Co For Pharmaceuticals And Chemical Industries - ElNile (CAI:NIPH) has a Total Operating Expense of E£363 Mil as of Mar. 2026. Total operating expense is the primary recurring expense associated with central operations. View historical data on El-Nile Co For Pharmaceuticals And Chemical Industries - ElNile and its competitors.
Is El-Nile Co For Pharmaceuticals And Chemical Industries - ElNile's Total Operating Expense too high?
El-Nile Co For Pharmaceuticals And Chemical Industries - ElNile's current Total Operating Expense is E£363 Mil. Overall, El-Nile Co For Pharmaceuticals And Chemical Industries - ElNile has a GF Score™ of 28/100, reflecting its overall financial health beyond just this single metric.
How does El-Nile Co For Pharmaceuticals And Chemical Industries - ElNile's Total Operating Expense compare to ZTS and UTHR?
El-Nile Co For Pharmaceuticals And Chemical Industries - ElNile's Total Operating Expense of E£363 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Operating Expense for a Drug Manufacturers company?
A good Total Operating Expense depends on the Drug Manufacturers industry context. However, Total Operating Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Operating Expense mean?
A high Total Operating Expense can signal that a stock is expensive relative to its fundamentals. Total operating expense is the primary recurring expense associated with central operations. View historical data on El-Nile Co For Pharmaceuticals And Chemical Industries - ElNile and its competitors. El-Nile Co For Pharmaceuticals And Chemical Industries - ElNile's current Total Operating Expense is E£363 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is El-Nile Co For Pharmaceuticals And Chemical Industries - ElNile stock overvalued right now?
El-Nile Co For Pharmaceuticals And Chemical Industries - ElNile (CAI:NIPH) has a current Total Operating Expense of E£363 Mil. The current Total Operating Expense is E£363 Mil. El-Nile Co For Pharmaceuticals And Chemical Industries - ElNile's overall GF Score™ is 28/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Operating Expense calculated?
Total Operating Expense is calculated from a company's financial statements. For El-Nile Co For Pharmaceuticals And Chemical Industries - ElNile (CAI:NIPH), the current Total Operating Expense is E£363 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

El-Nile Co For Pharmaceuticals And Chemical Industries - ElNile Business Description

Address Al-Sawah square, ElAmeria, Cairo, EGY
El-Nile Co For Pharmaceuticals And Chemical Industries - ElNile manufactures and markets pharmaceuticals, medicinal materials, chemical products and surgical threads and medical solutions.
28GF Score

Get the complete analysis for CAI:NIPH

Total Operating Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

E£184.90
Price